ActivMAb's new "Antigen Virus" application complements drug discovery strategies for complex protein targets, according to Vaccinex CEO. Ongoing partnerships can ...
Process engineering leader GEA Group plans to invest $20 million in an alternative proteins technology center in Wisconsin, accelerating development ...